• Curaleaf challenged Aurora Cannabis’ rejection of its enhanced acquisition offer, disputing the board’s October 14, 2026, recommendation.
• The $5-per-share offer represents an 86% premium to Aurora’s unaffected 30-day volume-weighted average share price, according to the bidder.
• Aurora has denied the bidder due diligence access while providing confidential information to other potential buyers, according to the challenge.
• The bidder remains ready to engage in due diligence, arguing negotiations could address Aurora’s concerns over offer conditions and synergy estimates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curaleaf Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE75049) on October 19, 2026, and is solely responsible for the information contained therein.